These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32012713)

  • 1. The Potential Role of Astrocytes in Parkinson's Disease (PD).
    Hindeya Gebreyesus H; Gebrehiwot Gebremichael T
    Med Sci (Basel); 2020 Jan; 8(1):. PubMed ID: 32012713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra.
    Zhang Y; Meng X; Jiao Z; Liu Y; Zhang X; Qu S
    ACS Chem Neurosci; 2020 Feb; 11(3):406-417. PubMed ID: 31909584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.
    Pajarillo E; Rizor A; Lee J; Aschner M; Lee E
    Neuropharmacology; 2019 Dec; 161():107559. PubMed ID: 30851309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of aquaporin-4 and excitatory amino acid transporter-2 indicate astrocyte dysfunction for pathogenesis of cortical degeneration in HIV-associated neurocognitive disorders.
    Xing HQ; Zhang Y; Izumo K; Arishima S; Kubota R; Ye X; Xu Q; Mori K; Izumo S
    Neuropathology; 2017 Feb; 37(1):25-34. PubMed ID: 27506782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of astroglial glutamate transporter GLT-1 in the lateral habenula is associated with depressive-like behaviors in a rat model of Parkinson's disease.
    Lyu S; Guo Y; Zhang L; Tang G; Li R; Yang J; Gao S; Li W; Liu J
    Neuropharmacology; 2021 Sep; 196():108691. PubMed ID: 34197892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.
    Lan YL; Zou S; Chen JJ; Zhao J; Li S
    Neural Plast; 2016; 2016():4626593. PubMed ID: 27057365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of glutamate transporter-1 and water channel protein aquaporin-4 in human temporal cortex with Alzheimer's disease.
    Hoshi A; Tsunoda A; Yamamoto T; Tada M; Kakita A; Ugawa Y
    Neuropathol Appl Neurobiol; 2018 Oct; 44(6):628-638. PubMed ID: 29405337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson's Disease Mice, Possibly via Impaired Glymphatic Clearance.
    Cui H; Wang W; Zheng X; Xia D; Liu H; Qin C; Tian H; Teng J
    J Mol Neurosci; 2021 Dec; 71(12):2500-2513. PubMed ID: 33772424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes: From the Physiology to the Disease.
    Trujillo-Estrada L; Gomez-Arboledas A; Forner S; Martini AC; Gutierrez A; Baglietto-Vargas D; LaFerla FM
    Curr Alzheimer Res; 2019; 16(8):675-698. PubMed ID: 31470787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation in Parkinson's disease and its potential as therapeutic target.
    Wang Q; Liu Y; Zhou J
    Transl Neurodegener; 2015; 4():19. PubMed ID: 26464797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of aquaporin-4 in synaptic plasticity, memory and disease.
    Hubbard JA; Szu JI; Binder DK
    Brain Res Bull; 2018 Jan; 136():118-129. PubMed ID: 28274814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy.
    Hubbard JA; Szu JI; Yonan JM; Binder DK
    Exp Neurol; 2016 Sep; 283(Pt A):85-96. PubMed ID: 27155358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Insight into the Molecular Mechanism of Mitochondrial Toxicant-induced Neuronal Apoptosis in Parkinson's Disease.
    Brahadeeswaran S; Lateef M; Calivarathan L
    Curr Mol Med; 2023; 23(1):63-75. PubMed ID: 35125081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial Glutamate Transporter-Mediated Plasticity: System x
    Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.